缺氧诱导因子-2α重编程肝脏巨噬细胞通过产生白细胞介素-6保护急性肝损伤
本研究探讨对乙酰氨基酚(APAP)诱导的急性肝损伤中缺氧诱导因子(HIF)-2α在肝脏巨噬细胞中的作用。通过髓系细胞特异性HIF-2α基因敲除小鼠及体外实验,发现HIF-2α缺失加重肝损伤,并减少保护性细胞因子白细胞介素-6(IL-6)的产生;外源性IL-6可改善损伤,而肝细胞IL-6受体敲除则消除保护作用。结论提示APAP通过稳定HIF-2α重编程巨噬细胞产生IL-6,从而减轻急性肝损伤。
要点
- APAP处理可稳定肝脏巨噬细胞中的HIF-2α。
- 髓系HIF-2α缺失加重APAP诱导的肝损伤。
- HIF-2α通过促进巨噬细胞IL-6产生发挥保护作用。
核心结论
- APAP处理导致肝脏巨噬细胞HIF-2α稳定,HIF-2α重编程巨噬细胞产生IL-6,从而改善急性肝损伤。
研究设计与样本
- 研究采用髓系细胞特异性HIF-2α基因敲除小鼠(HIF-2αmye-/-)和野生型小鼠,结合体外实验及肝细胞特异性IL-6受体敲除小鼠。
主要发现
- 与野生型小鼠相比,HIF-2αmye-/-小鼠在APAP攻击后肝脏和血清IL-6水平、肝细胞STAT3激活及肝脏巨噬细胞IL-6表达均显著降低,且肝损伤加重。
- 体外实验显示缺氧诱导肝脏巨噬细胞产生IL-6,该诱导在HIF-2α缺失的巨噬细胞中消失。
- 给予外源性IL-6可改善HIF-2αmye-/-小鼠的APAP诱导肝损伤。
- 在肝细胞特异性IL-6受体敲除小鼠中,IL-6介导的肝保护作用消失。
临床怎么用
- 提示HIF-2α–IL-6轴可能作为APAP诱导急性肝损伤的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Acetaminophen (APAP) overdose represents the most frequent cause of acute liver failure, resulting in death or liver transplantation in more than one third of patients in the United States. The effectiveness of the only antidote, N-acetylcysteine, declines rapidly after APAP ingestion, long before patients are admitted to the clinic with symptoms of severe liver injury. The direct hepatotoxicity of APAP triggers a cascade of innate immune responses that may exacerbate or limit the progression of tissue damage. A better understanding of this complex mechanism will help uncover targets for therapeutic interventions. APPROACH AND RESULTS: We observed that APAP challenge caused stabilization of hypoxia-inducible factors (HIFs) in the liver and hepatic macrophages (MΦs), particularly HIF-2α. Genetic deletion of the HIF-2α gene in myeloid cells (HIF-2αmye/- ) markedly exacerbated APAP-induced liver injury (AILI) without affecting APAP bioactivation and detoxification. In contrast, hepatic and serum levels of the hepatoprotective cytokine interleukin 6 (IL-6), its downstream signal transducer and transcription factor 3 activation in hepatocytes, as well as hepatic MΦ IL-6 expression were markedly reduced in HIF-2αmye/- mice compared to wild-type mice post-APAP challenge. In vitro experiments revealed that hypoxia induced IL-6 production in hepatic MΦs and that such induction was abolished in HIF-2α-deleted hepatic MΦs. Restoration of IL-6 by administration of exogenous IL-6 ameliorated AILI in HIF-2αmye/- mice. Finally, IL-6-mediated hepatoprotection against AILI was abolished in hepatocyte-specific IL-6 receptor knockout mice. CONCLUSIONS: The data demonstrate that APAP treatment leads to HIF-2α stabilization in hepatic MΦs and that HIF-2α subsequently reprograms hepatic MΦs to produce the hepatoprotective cytokine IL-6, thereby ameliorating AILI.
引用
- Gao RY, Wang M, Liu Q, et al. Hypoxia-Inducible Factor-2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury Through the Production of Interleukin-6. Hepatology. 2020. PMID: 31529728. doi:10.1002/hep.30954
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。